MTOR and prostate carcinoma: The PI3K/Akt/mTOR signaling pathway also inhibits autophagy in many types of human cancer cells, including ovarian cancer [33], HepG2 [34], prostate cancer [35], gastric cancer [36], and colorectal cancer cells [37].